Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 6/20 | 0.58 |
| ▸ | DPP3 | Q9NY33 | 2/20 | 0.58 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.57 |
| ▸ | CTSB | P07858 | 2/20 | 0.57 |
| ▸ | KISS1R | Q969F8 | 5/20 | 0.56 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.56 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.56 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.56 |
| ▸ | CTSL | P07711 | 3/20 | 0.53 |
| ▸ | CTSS | P25774 | 3/20 | 0.53 |
| ▸ | CTSK | P43235 | 3/20 | 0.53 |
| ▸ | CTSH | P09668 | 1/20 | 0.53 |
| ▸ | F13A1 | P00488 | 1/20 | 0.51 |
| ▸ | TGM2 | P21980 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30716436 | 0.95 | KISS1R (0.63) | CXCR4DPP3KISS1R | |
| SCHEMBL38652302 | 0.94 | CXCR4 (0.59) | CXCR4DPP3CAPN1CTSBKISS1R | |
| SCHEMBL29463744 | 0.93 | KISS1R (0.60) | CXCR4DPP3CAPN1CTSBKISS1R | |
| SCHEMBL31506622 | 0.93 | DPP3 (0.61) | CXCR4DPP3CAPN1CTSBKISS1R | |
| SCHEMBL31158220 | 0.92 | CXCR4 (0.68) | CXCR4CAPN1CTSBNTSR2NTSR1 | |
| SCHEMBL31290071 | 0.92 | CXCR4 (0.61) | CXCR4DPP3CAPN1CTSBKISS1R | |
| SCHEMBL31005883 | 0.92 | KISS1R (0.57) | CXCR4DPP3CAPN1CTSBKISS1R | |
| SCHEMBL29350708 | 0.91 | DPP3 (0.64) | CXCR4DPP3CAPN1CTSBKISS1R | |
| SCHEMBL29463717 | 0.91 | CAPN1 (0.63) | CXCR4DPP3CAPN1CTSBKISS1R | |
| SCHEMBL32681271 | 0.90 | DPP3 (0.66) | DPP3CAPN1CTSBKISS1RNTSR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260060913-A1 | BIOACTIVE WALNUT PEPTIDES FOR TREATING HAIR LOSS | L'OREAL (FR) | 2026-03-05 | — | — | US | claimed |
| US-20250213646-A1 | BIOACTIVE WALNUT PEPTIDES AND COMPOSITIONS FOR TREATING SKIN | L'OREAL (FR) | 2025-07-03 | — | — | US | claimed |
| WO-2025096719-A1 | BIOACTIVE WALNUT PEPTIDES AND COMPOSITIONS FOR TOPICAL TREATMENT OF SKIN | L'OREAL (FR) | 2025-05-08 | — | — | WO | claimed |
| US-20250134794-A1 | BIOACTIVE WALNUT PEPTIDES AND COMPOSITIONS FOR TOPICAL TREATMENT OF SKIN | L'OREAL (FR) | 2025-05-01 | — | — | US | claimed |
| US-20260060913-A1 | BIOACTIVE WALNUT PEPTIDES FOR TREATING HAIR LOSS | L'OREAL (FR) | 2026-03-05 | — | — | US | disclosed |
| US-20250213646-A1 | BIOACTIVE WALNUT PEPTIDES AND COMPOSITIONS FOR TREATING SKIN | L'OREAL (FR) | 2025-07-03 | — | — | US | disclosed |
| WO-2025096719-A1 | BIOACTIVE WALNUT PEPTIDES AND COMPOSITIONS FOR TOPICAL TREATMENT OF SKIN | L'OREAL (FR) | 2025-05-08 | — | — | WO | disclosed |
| US-20250134794-A1 | BIOACTIVE WALNUT PEPTIDES AND COMPOSITIONS FOR TOPICAL TREATMENT OF SKIN | L'OREAL (FR) | 2025-05-01 | — | — | US | disclosed |
| CN-117426369-A | Antioxidant additive for cryopreservation of oocytes and application of antioxidant additive | 四川农业大学 | 2024-01-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260060913-A1 | BIOACTIVE WALNUT PEPTIDES FOR TREATING HAIR LOSS | TYR, CUTA, ARGLU1 | CXCR4 4395/4885DPP3 1619/4885CAPN1 1600/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.